Arkolith/Insider Trading/AVIR/Form 4/A

Murphy Polly A.

DirectorAtea Pharmaceuticals, Inc. (AVIR) · full profile →Form 4/A · filed May 21, 2026
Net Buying
Open-Market Buys
$25K
Open-Market Sells
$0
Net Open-Market Flow
$25K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 18, 2026Buy(P)6K$4.17$25K92K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001193125-26-235039) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML